Contact this trialFirst, we need to learn more about you.
CDK4/6 Inhibitor
Genetically-informed Therapy for Advanced Breast Cancer
Recruiting1 awardPhase 2
Lebanon, New Hampshire
This trial is testing combinations of medicines to treat advanced ER+/HER2- breast cancer. It focuses on patients who have previously received certain treatments. The goal is to find out if using multiple drugs together can work better than previous treatments. The medicines being tested are approved for treating HR-positive, HER2-negative metastatic breast cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service